Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Cell Apoptosi
2026-06-15
The Annexin V-Cy5/DAPI Apoptosis Kit streamlines rapid, dual-parameter detection of apoptosis and necrosis, empowering researchers to decode complex cell death pathways in under 20 minutes. Its high sensitivity and workflow simplicity make it indispensable for mechanistic studies, including mitochondrial apoptosis in leukemia models.
-
Protease Inhibitor Cocktail: Enhancing Lipid Droplet Researc
2026-06-14
Unlock high-fidelity protein extractions in lipid metabolism studies with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). This ready-to-use solution from APExBIO ensures robust protein stability during workflows involving DFCP1 and ATGL, supporting reproducible analysis of metabolic adaptations.
-
Angiotensin II in Vascular Remodeling and Hypertension Model
2026-06-13
APExBIO’s Angiotensin II enables reproducible modeling of hypertension and vascular injury through well-defined workflows in both cell-based and animal studies. Recent evidence highlights how strategic pairing with metabolic modulators, such as benzyl alcohol, can reveal new therapeutic avenues and assay optimizations for cardiovascular remodeling research.
-
Enhancing Assay Reliability with Angiotensin 1/2 (5-7): SKU
2026-06-12
This article offers scenario-driven guidance for researchers optimizing cell-based and molecular assays with Angiotensin 1/2 (5-7) (SKU A1049). Drawing on validated data and recent mechanistic insights, it demonstrates how APExBIO’s high-purity H2N-Ile-His-Pro-OH peptide streamlines renin-angiotensin system research, improves reproducibility, and bridges cardiovascular and viral pathogenesis workflows.
-
Taxus chinensis Fruit Extract Inhibits Neuroinflammation via
2026-06-12
This study demonstrates that Taxus chinensis fruit extract (TCFE) significantly attenuates aging behaviors and neuroinflammation by inhibiting microglia activation through the TLR4/NF-κB/NLRP3 pathway. These findings establish a mechanistic foundation for the use of TCF-derived compounds in neuroinflammation and aging research, offering new directions for targeted anti-inflammatory strategies.
-
Angiotensin II in AAA Models: Senescence, Biomarkers, and Pr
2026-06-11
Discover how Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) enables precise vascular research, with a focus on senescence biomarkers in abdominal aortic aneurysm models. This article uniquely integrates molecular mechanisms, emerging diagnostics, and advanced experimental protocols.
-
BIBP 3226 trifluoroacetate: Specific NPY/NPFF Antagonism in
2026-06-11
BIBP 3226 trifluoroacetate is a potent, selective non-peptide antagonist for NPY Y1 and NPFF receptors, enabling precise dissection of neuropeptide-driven mechanisms in anxiety, analgesia, and cardiovascular regulation. The compound’s high affinity and reliable performance make it a preferred tool for NPY/NPFF system research, as confirmed by recent mechanistic studies and validated product documentation. Targeted application supports novel experimental models of adipose-neural signaling in cardiac arrhythmia.
-
Novobiocin: Applied Workflows for Antibacterial Resistance R
2026-06-10
Novobiocin, an aminocoumarin antibiotic, empowers advanced research across antibacterial, antiparasitic, and antiviral domains. This article explores protocol enhancements, troubleshooting strategies, and unique mechanistic insights—bridging bench discoveries with optimized experimental design.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui
2026-06-10
DiI (DiIC18(3)) is designed for robust, selective plasma membrane labeling in live and fixed samples. It addresses the need for high-contrast membrane visualization, neuronal tracing, and cell migration analysis, but should not be used for aqueous-only protocols or intracellular organelle staining.
-
Baicalin Restores Visual Cortex Plasticity in Adult Amblyopi
2026-06-09
The referenced study demonstrates that baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity and restores visual acuity in adult mice with amblyopia. These findings highlight a mechanistic link between baicalin-mediated reduction of cortical inhibition and functional recovery, offering new directions for safe, targeted pharmacological interventions in adult neuroplasticity disorders.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina
2026-06-09
This study demonstrates that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) suppresses triple-negative breast cancer by inducing ferroptosis through the CUL3–MTDH axis. The mechanistic insights and in vivo efficacy highlight a promising direction for ferroptosis-based cancer therapies.
-
Platanoside Inhibits Ferroptosis in ALI via Keap1-Nrf2-GPX4
2026-06-08
This study demonstrates that platanoside prevents ferroptosis-driven acute lung injury by promoting autophagy-dependent Keap1 degradation, thereby activating the Nrf2/GPX4 antioxidant axis. The findings reveal a novel mechanism for mitigating oxidative and inflammatory damage in lung tissue, supporting new directions for redox-targeted therapies.
-
Angiotensin 1/2 (5-7): Reliable Solutions for Cell Assays
2026-06-08
This article explores laboratory challenges in cell viability, proliferation, and cytotoxicity assays, and demonstrates how Angiotensin 1/2 (5-7) (SKU A1049) provides reproducible, data-backed solutions. Drawing on peer-reviewed evidence and scenario-driven analysis, it guides biomedical researchers on optimizing renin-angiotensin system research workflows using high-purity H2N-Ile-His-Pro-OH peptide reagents.
-
n-Dodecyl-β-D-maltoside: Optimized Workflows for Membrane Pr
2026-06-07
n-Dodecyl-β-D-maltoside (DDM) is the membrane protein purification reagent of choice for challenging targets like WecA, enabling gentle solubilization and stabilization that preserves native function. Here, we translate recent advances into actionable protocols, troubleshooting tips, and practical guidance for maximizing yield and assay integrity.
-
Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl
2026-06-06
This study elucidates how Polo-like kinase 1 (Plk1) modulates the activity of p31comet during the disassembly of mitotic checkpoint complexes (MCC), a critical process for accurate chromosome segregation. By mapping Plk1-dependent phosphorylation of p31comet and detailing its functional consequences, the research advances our understanding of mitotic checkpoint regulation with implications for cell cycle and cancer biology.